Literature DB >> 21880774

The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.

Christina Montag1, Jutta Annabella Wagner, Iris Gruska, Barbara Vetter, Lüder Wiebusch, Christian Hagemeier.   

Abstract

Many viruses antagonize tumor necrosis factor alpha (TNF-α) signaling in order to counteract its antiviral properties. One way viruses achieve this goal is to reduce TNF-α receptor 1 (TNFR1) on the surface of infected cells. Such a mechanism is also employed by human cytomegalovirus (HCMV), as recently reported by others and us. On the other hand, TNF-α has also been shown to foster reactivation of HCMV from latency. By characterizing a new variant of HCMV AD169, we show here that TNFR1 downregulation by HCMV only becomes apparent upon infection of cells with HCMV strains lacking the so-called ULb' region. This region contains genes involved in regulating viral immune escape, cell tropism, or latency and is typically lost from laboratory strains but present in low-passage strains and clinical isolates. We further show that although ULb'-positive viruses also contain the TNFR1-antagonizing function, this activity is masked by a dominant TNFR1 upregulation mediated by the ULb' gene product UL138. Isolated expression of UL138 in the absence of viral infection upregulates TNFR1 surface expression and can rescue both TNFR1 reexpression and TNF-α responsiveness of cells infected with an HCMV mutant lacking the UL138-containing transcription unit. Given that the UL138 gene product is one of the few genes recognized to be expressed during HCMV latency and the known positive effects of TNF-α on viral reactivation, we suggest that via upregulating TNFR1 surface expression UL138 may sensitize latently infected cells to TNF-α-mediated reactivation of HCMV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880774      PMCID: PMC3194957          DOI: 10.1128/JVI.05028-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique.

Authors:  Gabriele Hahn; Dietlind Rose; Markus Wagner; Sylvia Rhiel; Michael A McVoy
Journal:  Virology       Date:  2003-03-01       Impact factor: 3.616

2.  General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.

Authors:  Martin Zydek; Ralf Uecker; Nina Tavalai; Thomas Stamminger; Christian Hagemeier; Lüder Wiebusch
Journal:  J Gen Virol       Date:  2011-08-10       Impact factor: 3.891

3.  Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface.

Authors:  N Neznanov; A Kondratova; K M Chumakov; B Angres; B Zhumabayeva; V I Agol; A V Gudkov
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

Authors:  Maria Filippova; Helen Song; Jodi L Connolly; Terence S Dermody; Penelope J Duerksen-Hughes
Journal:  J Biol Chem       Date:  2002-04-04       Impact factor: 5.157

5.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Fatal attraction: cytomegalovirus-encoded chemokine homologs.

Authors:  N Saederup; E S Mocarski
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 7.  The human cytomegalovirus.

Authors:  Santo Landolfo; Marisa Gariglio; Giorgio Gribaudo; David Lembo
Journal:  Pharmacol Ther       Date:  2003-06       Impact factor: 12.310

8.  Functional profiling of a human cytomegalovirus genome.

Authors:  Walter Dunn; Cassie Chou; Hong Li; Rong Hai; David Patterson; Viktor Stolc; Hua Zhu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

Review 9.  Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis.

Authors:  G Herbein; W A O'Brien
Journal:  Proc Soc Exp Biol Med       Date:  2000-03

10.  Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.

Authors:  J Baillie; D A Sahlender; J H Sinclair
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  44 in total

1.  The Golgi sorting motifs of human cytomegalovirus UL138 are not required for latency maintenance.

Authors:  Christopher B Gelbmann; Robert F Kalejta
Journal:  Virus Res       Date:  2019-06-28       Impact factor: 3.303

2.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

3.  The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Authors:  Vu Thuy Khanh Le-Trilling; Ofer Mandelboim; Liat Dassa; Einat Seidel; Esther Oiknine-Djian; Rachel Yamin; Dana G Wolf
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 4.  Manipulation of host pathways by human cytomegalovirus: insights from genome-wide studies.

Authors:  Yifat Cohen; Noam Stern-Ginossar
Journal:  Semin Immunopathol       Date:  2014-09-27       Impact factor: 9.623

5.  Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity.

Authors:  Nicole Gudleski-O'Regan; Todd M Greco; Ileana M Cristea; Thomas Shenk
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

6.  The Membrane-Spanning Peptide and Acidic Cluster Dileucine Sorting Motif of UL138 Are Required To Downregulate MRP1 Drug Transporter Function in Human Cytomegalovirus-Infected Cells.

Authors:  Christopher B Gelbmann; Robert F Kalejta
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

7.  Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Authors:  Vanessa M Noriega; Kester K Haye; Thomas A Kraus; Shanna R Kowalsky; Yongchao Ge; Thomas M Moran; Domenico Tortorella
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

8.  The human cytomegalovirus UL26 protein antagonizes NF-κB activation.

Authors:  Chun Mathers; Xenia Schafer; Luis Martínez-Sobrido; Joshua Munger
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

9.  Complex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication.

Authors:  Katie Caviness; Louis Cicchini; Michael Rak; Mahadevaiah Umashankar; Felicia Goodrum
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

10.  Human Cytomegalovirus Latency: Approaching the Gordian Knot.

Authors:  Felicia Goodrum
Journal:  Annu Rev Virol       Date:  2016-08-04       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.